Amplifon stock: Q3 margins improve as GN Hearing deal advances

Amplifon delivered stronger profitability in the third quarter and cleared another transaction milestone on Thursday, October 29. HearingTracker reported that shareholders approved the issue of 56 million Amplifon shares to GN as part of the planned acquisition of GN Hearing.

The company reported third-quarter revenue of 575 million euros, up 2.1% year on year, while organic growth reached 3.6%. Adjusted EBITDA rose 7% to 114.8 million euros, lifting the margin to 20%, and adjusted net profit climbed 38.7% to 26.6 million euros, according to HearingTracker.

Profitability leads the quarterly performance

For the first nine months, revenue rose to 1.76 billion euros and adjusted net profit increased 16.9%. The improvement in earnings outpaced sales growth as Amplifon's Fit4Growth program and operating leverage supported margins. Restructuring measures, including the closure of underperforming clinics and the termination of a US managed-care agreement, also weighed on reported revenue.

Amplifon kept its full-year forecast unchanged. Management continues to target organic revenue growth above 3% and an adjusted EBITDA margin improvement of roughly one percentage point. The quarter therefore strengthens the operating case, while the unchanged guidance leaves execution in the final quarter as the next key test.

GN Hearing deal reaches another milestone

The planned 2.3 billion euro acquisition of GN Hearing moved forward with the shareholder approval. Amplifon expects to complete the transaction by the end of 2026, subject to regulatory approvals and the separation of GN Hearing from its parent company. Integration preparations are described as being on schedule.

The real-time quote of Amplifon stock shows a trade at 11.18 euros on Lang & Schwarz at 10:38 Berlin time on Saturday, October 31, 2026.

Italian equities remain linked to the FTSE MIB market environment.

Find more news and analyses on Amplifon stock.